Involvement of kainate receptors in the analgesic but not hypnotic effects induced by inhalation anesthetics

Pharmacological Reports

Volumn 63, Issue 4, 2011, Pages 949-955

  Hang, Li Hua ^a   Shao, Dong Hua ^a   Gu, Yue Ping ^a   Dai, Ti Jun ^b  

^a JIANGSU UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Analgesia; Hypnosis; Inhalation anesthetics; KA receptors

Indexed keywords

ENFLURANE; ISOFLURANE; KAINIC ACID; KAINIC ACID RECEPTOR; SEVOFLURANE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; EXPERIMENTAL TEST; HYPNOTIC EFFECT; IN VIVO STUDY; LATENT PERIOD; MOUSE; NONHUMAN; SLEEP TIME; TAIL WITHDRAWAL TEST;

EID: 80053350046     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70610-7     Document Type: Article

References (29)

1. Abraham MH, Acree WE Jr, Mintz C, Payne S: Effect of anesthetic structure on inhalation anesthesia: implications for the mechanism. J Pharm Sci, 2008, 97, 2373-2384.
2. Akk G, Mennerick S, Steinbach JH: Actions of anesthetics on excitatory transmitter-gated channels. Handb Exp Pharmacol, 2008, 182, 53-84.
3. Antognini JF, Carstens E: In vivo characterization of clinical anaesthesia and its components. Br J Anaesth, 2002, 89, 156-166. (Pubitemid 34778111)
4. Bantel C, Maze M, Trapp S: Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener. Anesthesiology, 2010, 112, 623-630.
5. Chiari PC, Pagel PS, Tanaka K, Krolikowski JG, Ludwig LM, Trillo RA Jr, Puri N et al.: Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits. Anesthesiology, 2004, 101, 1160-1166. (Pubitemid 39430796)
6. Coussen F: Molecular determinants of kainate receptor trafficking. Neuroscience, 2009, 158, 25-35.
7. Dableh LJ, Yashpal K, Henry JL: Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist. Eur J Pharmacol, 2009, 602, 36-40.
8. Dinse A, Föhr KJ, Georgieff M, Beyer C, Bulling A, Weigt HU: Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones. Br J Anaesth, 2005, 94, 479-485.
9. Dominguez E, Iyengar S, Shannon HE, Bleakman D, Alt A, Arnold BM, Bell MG et al.: Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain. J Med Chem, 2005, 48, 4200-4203. (Pubitemid 40894646)
10. Hang LH, Shao DH, Wang H, Yang JP: Involvement of 5-hydroxytryptamine type 3 receptors in sevoflurane-induced hypnotic and analgesic effects in mice. Pharmacol Rep, 2010, 62, 621-626.
11. Hylden JL, Wilcox GL: Intrathecal morphine in mice: a new technique. Eur J Pharmacol, 1980, 67, 313-316. (Pubitemid 10007057)
12. Ko S, Zhao MG, Toyoda H, Qiu CS, Zhuo M: Altered behavioral responses to noxious stimuli and fear in glutamate receptor 5 (GluR5)- or GluR6-deficient mice. J Neurosci, 2005, 25, 977-984. (Pubitemid 40171014)
13. Laursen SE, Belknap JK: Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods, 1986, 16, 355-357. (Pubitemid 17189961)
14. Lerma J: Kainate receptor physiology. Curr Opin Pharmacol, 2006, 6, 89-97.
15. Mantz J, Dahmani S: Exploring the mechanisms of general anesthesia. Acta Anaesthesiol Belg, 2008, 59, 167-171.
16. Nguyen HT, Li KY, DaGraca RL, Delphin E, Xiong M, Ye JH: Behavior and cellular evidence for propofol-induced hypnosis involving brain glycine receptors. Anesthesiology, 2009, 110, 326-332.
17. Pinheiro P, Mulle C: Kainate receptors. Cell Tissue Res, 2006, 326, 457-482. (Pubitemid 44444793)
18. Rampil IJ: Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology, 1994, 80, 606-610.
19. Rampil IJ, Mason P, Singh H: Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology, 1993, 78, 707-712. (Pubitemid 23110045)
20. A receptor γ2 subunit expression potentiates the immobilizing action of isoflurane. Neurosci Lett, 2010, 472, 1-4.
21. Solt K, Forman SA: Correlating the clinical actions and molecular mechanisms of general anesthetics. Curr Opin Anaesthesiol, 2007, 20, 300-306. (Pubitemid 47051888)
22. Sonner JM, Vissel B, Royle G, Maurer A, Gong D, Baron NV, Harrison N et al.: The effect of three inhaled anesthetics in mice harboring mutations in the GluR6 (kainate) receptor gene. Anesth Analg, 2005, 101, 143-148. (Pubitemid 40853365)
23. 1 γ-aminobutyric acid type A receptors unresponsive to isoflurane. Anesthesiology, 2007, 106, 107-113.
24. Tao F, Skinner J, Yang Y, Johns RA: Effect of PSD-95/SAP90 and/or PSD-93/chapsyn-110 deficiency on the minimum alveolar anesthetic concentration of halothane in mice. Anesthesiology, 2010, 112, 1444-1451.
25. Urban BW: Current assessment of targets and theories of anaesthesia. Br J Anaesth, 2002, 89, 167-183.
26. Urban BW: The site of anesthetic action. Handb Exp Pharmacol, 2008, 182, 3-29.
27. Wu LJ, Ko SW, Zhuo M: Kainate receptors and pain: from dorsal root ganglion to the anterior cingulate cortex. Curr Pharm Des, 2007, 13, 1597-1605. (Pubitemid 46860862)
28. Yang XL, Ma HX, Yang ZB, Liu AJ, Luo NF, Zhang WS, Wang L et al.: Comparison of minimum alveolar concentration between intravenous isoflurane lipid emulsion and inhaled isoflurane in dogs. Anesthesiology, 2006, 104, 482-487.
29. Zhou JX, Luo NF, Liang XM, Liu J: The efficacy and safety of intravenous emulsified isoflurane in rats. Anesth Analg, 2006, 102,129-134.